TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SD4MA35

Real-time Boerse Frankfurt Warrants 09:44:02 2024-06-03 EDT
5.16 EUR +6.61% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
1 month-9.53%
3 months-7.10%
Date Price Change
24-06-03 5.16 +6.61%
24-05-31 4.84 +0.21%
24-05-30 4.83 -2.42%
24-05-29 4.95 +0.81%
24-05-28 4.91 -4.84%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 09:44 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SD4MA3
ISINDE000SD4MA35
Date issued 2021-03-12
Strike 72.95 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.86
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.61
Lowest since issue 0.63
Spread 0.06
Spread %1.22%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus